Researchers develop scalable method to produce immune cells for cancer therapy

Scientists at Boston Medical Center and Boston University have created a new technique to generate CD4+ helper T cells from stem cells, addressing a major hurdle in immunotherapy development.

The method, detailed in the journal Stem Cell Reports, allows for large-scale production of these immune cells, which are crucial for activating other immune responses against cancer.

This breakthrough may pave the way for widely available CAR-T cell therapies, which are currently customized for individual patients and costly to produce.

The research team emphasizes that further studies are needed before the technique can be used in clinical settings.

Based on reporting from Medical Xpress (Cancer).

Source: Medical Xpress (Cancer). This article was drafted by AI from that reporting and reviewed by an automated accuracy check before publishing.